Berita Valas

Euro Higher Against Majors

Euro Higher Against Majors

The euro advanced against its major counterparts in the European session on Thursday, as the dollar took a breather after a strong rally.
RTTNews | 1093 hari yang lalu
U.S. Pending Home Sales Plunge Much More Than Expected In August

U.S. Pending Home Sales Plunge Much More Than Expected In August

A report released by the National Association of Realtors on Thursday showed a much steeper than expected drop in U.S. pending home sales in the month of August. NAR said its pending home sales plunged by 7.1 percent to 71.8 in August after rising by 0.5 percent to a downwardly revised 77.3 in July.
RTTNews | 1093 hari yang lalu
U.S. Economic Growth Unrevised At 2.1% In Second Quarter

U.S. Economic Growth Unrevised At 2.1% In Second Quarter

The Commerce Department released a report on Thursday showing the pace of U.S. economic growth in the second quarter of 2023 was unrevised from the previous estimate. The report said real gross domestic product increased by 2.1 percent in the second quarter, unrevised from the estimate provided last month. The unrevised reading matched economist estimates.
RTTNews | 1093 hari yang lalu
U.S. Weekly Jobless Claims Show Slight Uptick From Seven-Month Low

U.S. Weekly Jobless Claims Show Slight Uptick From Seven-Month Low

After reporting first-time claims for U.S. unemployment benefits fell to a seven-month low in the previous week, the Labor Department released a report on Thursday showing a slight increase in initial jobless claims in the week ended September 23rd. The Labor Department said initial jobless claims crept up to 204,000, an increase of 2,000 from the previous week's revised level of 202,000.
RTTNews | 1093 hari yang lalu
Allegiant Travel CEO John Redmond Resigns

Allegiant Travel CEO John Redmond Resigns

Allegiant Travel Co. (ALGT) announced Thursday that John Redmond has resigned as chief executive officer and as a member of the Board of Directors effective immediately. Maurice Gallagher, former CEO, current executive chairman and one of the Company's largest stockholders, will resume the CEO role.
RTTNews | 1093 hari yang lalu
German Inflation Weakest Since Early 2022

German Inflation Weakest Since Early 2022

Germany inflation slowed in September to the lowest since the outbreak of the war in Ukraine, provisional data from Destatis showed on Thursday. The consumer price index registered an annual increase of 4.5 percent in September, following a 6.1 percent rise in August. This was the lowest rate since February 2022, when inflation stood at 4.3 percent.
RTTNews | 1093 hari yang lalu
Berita lainnya
Eastman Chemical To Sell Its Texas City Operations To INEOS Acetyls

Eastman Chemical To Sell Its Texas City Operations To INEOS Acetyls

Eastman Chemical Co. (EMN) announced Thursday it has entered into a definitive agreement to sell its Texas City Operations to INEOS Acetyls, a global manufacturer and supplier of acetic acid and related chemicals owned by the INEOS Group.
RTTNews | 1093 hari yang lalu
Cognizant Appoints Jatin Dalal To Succeed Jan Siegmund As CFO

Cognizant Appoints Jatin Dalal To Succeed Jan Siegmund As CFO

Professional services company Cognizant Technology Solutions Corp. (CTSH) announced Thursday the appointment of Jatin Dalal as Chief Financial Officer, with the appointment anticipated to be effective in December 2023.
RTTNews | 1093 hari yang lalu
U.S. Second Quarter GDP Growth Unrevised At 2.1%

U.S. Second Quarter GDP Growth Unrevised At 2.1%

The pace of U.S. economic growth in the second quarter of 2023 was unrevised from the previous estimate, the Commerce Department revealed in a report released by on Thursday.
RTTNews | 1093 hari yang lalu
Dollar Drops After U.S. GDP Data

Dollar Drops After U.S. GDP Data

U.S. weekly jobless claims for the week ended September 23 and final GDP data for the second quarter have been published at 8.30 am ET Thursday. After these data, the greenback fell against its major counterparts.
RTTNews | 1093 hari yang lalu
Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.
RTTNews | 1093 hari yang lalu

Tetap ikuti informasi terbaru!

Tambahkan Berita ke browser Anda

Extension Picture